Kerényi A - Search Results

1

[Activity of natural coagulation inhibitor proteins in the acute phase of ischaemic stroke].

Oláh L, Csépány T, Bereczky Z, Kerényi A, Misz M, Kappelmayer J, Csiba L. Oláh L, et al. Among authors: kerenyi a. Ideggyogy Sz. 2005 Jan 20;58(1-2):33-9. Ideggyogy Sz. 2005. PMID: 15884396 Hungarian.

2

A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa.

Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerényi A, Balogh I, Muszbek L. Losonczy G, et al. Among authors: kerenyi a. Thromb Haemost. 2005 May;93(5):904-9. doi: 10.1160/TH04-12-0848. Thromb Haemost. 2005. PMID: 15886807

3

Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency.

Ajzner E, Schlammadinger A, Kerényi A, Bereczky Z, Katona E, Haramura G, Boda Z, Muszbek L. Ajzner E, et al. Among authors: kerenyi a. Blood. 2009 Jan 15;113(3):723-5. doi: 10.1182/blood-2008-09-179333. Epub 2008 Oct 27. Blood. 2009. PMID: 18955560 Free article.

4

Potential therapeutic targeting of platelet-mediated cellular interactions in atherosclerosis and inflammation.

Nagy B Jr, Miszti-Blasius K, Kerenyi A, Clemetson KJ, Kappelmayer J. Nagy B Jr, et al. Among authors: kerenyi a. Curr Med Chem. 2012;19(4):518-31. doi: 10.2174/092986712798918770. Curr Med Chem. 2012. PMID: 22204330 Review.

5

Rapid-onset heparin-induced thrombocytopenia without previous heparin exposure.

Olah Z, Kerenyi A, Kappelmayer J, Schlammadinger A, Razso K, Boda Z. Olah Z, et al. Among authors: kerenyi a. Platelets. 2012;23(6):495-8. doi: 10.3109/09537104.2011.650245. Epub 2012 Feb 6. Platelets. 2012. PMID: 22309045 Free article.

6

Direct thrombin inhibitors and factor xa inhibitors can influence the diluted prothrombin time used as the initial screen for lupus anticoagulant.

Olah Z, Szarvas M, Bereczky Z, Kerenyi A, Kappelmayer J, Boda Z. Olah Z, et al. Among authors: kerenyi a. Arch Pathol Lab Med. 2013 Jul;137(7):967-73. doi: 10.5858/arpa.2012-0236-OA. Arch Pathol Lab Med. 2013. PMID: 23808469 Free article.

7

The superiority of anti-FXa assay over anti-FIIa assay in detecting heparin-binding site antithrombin deficiency.

Kovács B, Bereczky Z, Oláh Z, Gindele R, Kerényi A, Selmeczi A, Boda Z, Muszbek L. Kovács B, et al. Among authors: kerenyi a. Am J Clin Pathol. 2013 Nov;140(5):675-9. doi: 10.1309/AJCPVY4Z9XZMFOTH. Am J Clin Pathol. 2013. PMID: 24124146 Clinical Trial.

8

Progressive chromogenic anti-factor Xa assay and its use in the classification of antithrombin deficiencies.

Kovács B, Bereczky Z, Selmeczi A, Gindele R, Oláh Z, Kerényi A, Boda Z, Muszbek L. Kovács B, et al. Among authors: kerenyi a. Clin Chem Lab Med. 2014 Dec;52(12):1797-806. doi: 10.1515/cclm-2014-0246. Clin Chem Lab Med. 2014. PMID: 24968404

9

[Pneumatic tube system for transport of laboratory samples: preanalytical aspects].

Tóth J, Lenkey Á, V Oláh A, Köteles J, Kissné Sziráki V, Kerényi A, Kappelmayer J. Tóth J, et al. Among authors: kerenyi a. Orv Hetil. 2014 Jul 13;155(28):1113-20. doi: 10.1556/OH.2014.29895. Orv Hetil. 2014. PMID: 25002315 Hungarian.

10

The use of recombinant factor XIII in a major bleeding episode of a patient with congenital factor XIII deficiency--the first experience.

Árokszállási A, Kerényi A, Katona É, Bereczky Z, Muszbek L, Boda Z, Schlammadinger Á. Árokszállási A, et al. Among authors: kerenyi a. Haemophilia. 2015 Jan;21(1):e118-21. doi: 10.1111/hae.12591. Epub 2014 Dec 4. Haemophilia. 2015. PMID: 25471755 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

89 results

Search Page

Filters